KRAS G12V Mutant Advanced Epithelial Cancers (DBCOND0148790)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT05389514	Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors	Cyclophosphamide Gemcitabine Pembrolizumab	Not Available	Not Available	available